CN116390650A - Edible eel culture - Google Patents
Edible eel culture Download PDFInfo
- Publication number
- CN116390650A CN116390650A CN202180067858.8A CN202180067858A CN116390650A CN 116390650 A CN116390650 A CN 116390650A CN 202180067858 A CN202180067858 A CN 202180067858A CN 116390650 A CN116390650 A CN 116390650A
- Authority
- CN
- China
- Prior art keywords
- eel
- weight
- edible
- eels
- feed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002632 lipids Chemical class 0.000 claims abstract description 42
- 210000002027 skeletal muscle Anatomy 0.000 claims abstract description 28
- 235000013372 meat Nutrition 0.000 claims abstract description 24
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 23
- 235000010469 Glycine max Nutrition 0.000 claims description 66
- 244000068988 Glycine max Species 0.000 claims description 66
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 65
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 65
- 235000008696 isoflavones Nutrition 0.000 claims description 65
- 230000037396 body weight Effects 0.000 claims description 49
- 238000009395 breeding Methods 0.000 claims description 24
- 230000001488 breeding effect Effects 0.000 claims description 23
- 239000011521 glass Substances 0.000 claims description 23
- 230000002710 gonadal effect Effects 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 8
- 210000001015 abdomen Anatomy 0.000 claims description 7
- 210000000577 adipose tissue Anatomy 0.000 claims description 7
- 241000252073 Anguilliformes Species 0.000 abstract description 61
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 42
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 41
- 235000006539 genistein Nutrition 0.000 description 41
- 229940045109 genistein Drugs 0.000 description 41
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 30
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 30
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 30
- 235000018102 proteins Nutrition 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 18
- 238000000034 method Methods 0.000 description 16
- 239000000411 inducer Substances 0.000 description 15
- 210000002149 gonad Anatomy 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 9
- 238000010411 cooking Methods 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- -1 flavonoid compounds Chemical class 0.000 description 7
- 229930182470 glycoside Natural products 0.000 description 7
- 150000002338 glycosides Chemical class 0.000 description 7
- 241000252087 Anguilla japonica Species 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000004069 differentiation Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 235000019733 Fish meal Nutrition 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 239000004467 fishmeal Substances 0.000 description 5
- 235000010355 mannitol Nutrition 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 235000003687 soy isoflavones Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- 241000252082 Anguilla anguilla Species 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000252089 Anguilla marmorata Species 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005306 natural glass Substances 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 241000252084 Anguilla Species 0.000 description 2
- 241000252085 Anguilla rostrata Species 0.000 description 2
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 206010049290 Feminisation acquired Diseases 0.000 description 2
- 208000034793 Feminization Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 235000012730 carminic acid Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- OZBAVEKZGSOMOJ-MIUGBVLSSA-N glycitin Chemical compound COC1=CC(C(C(C=2C=CC(O)=CC=2)=CO2)=O)=C2C=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OZBAVEKZGSOMOJ-MIUGBVLSSA-N 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000007951 isotonicity adjuster Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000003075 phytoestrogen Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000020509 sex determination Effects 0.000 description 2
- 229940083037 simethicone Drugs 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- YGZFYDFBHIDIBH-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCC(CO)N(CCO)CCO YGZFYDFBHIDIBH-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- AEDQNOLIADXSBB-UHFFFAOYSA-N 3-(dodecylazaniumyl)propanoate Chemical compound CCCCCCCCCCCCNCCC(O)=O AEDQNOLIADXSBB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- CEZCCHQBSQPRMU-LLIZZRELSA-L Allura red AC Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1\N=N\C1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-LLIZZRELSA-L 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000000940 FEMA 2235 Substances 0.000 description 1
- 239000004214 Fast Green FCF Substances 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 1
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- XJTZHGNBKZYODI-UHFFFAOYSA-N Glycitin Natural products OCC1OC(Oc2ccc3OC=C(C(=O)c3c2CO)c4ccc(O)cc4)C(O)C(O)C1O XJTZHGNBKZYODI-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- OIQPTROHQCGFEF-QIKYXUGXSA-L Sunset Yellow FCF Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-QIKYXUGXSA-L 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- ZIALXKMBHWELGF-UHFFFAOYSA-N [Na].[Cu] Chemical compound [Na].[Cu] ZIALXKMBHWELGF-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 235000012741 allura red AC Nutrition 0.000 description 1
- 239000004191 allura red AC Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012665 annatto Nutrition 0.000 description 1
- 239000010362 annatto Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 239000004161 brilliant blue FCF Substances 0.000 description 1
- 229940055580 brilliant blue fcf Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940080423 cochineal Drugs 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019240 fast green FCF Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 150000002272 genistein Chemical class 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 description 1
- 235000008466 glycitein Nutrition 0.000 description 1
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 description 1
- 229960003988 indigo carmine Drugs 0.000 description 1
- 235000012738 indigotine Nutrition 0.000 description 1
- 239000004179 indigotine Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 125000000346 malonyl group Chemical group C(CC(=O)*)(=O)* 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940081623 rose bengal Drugs 0.000 description 1
- 229930187593 rose bengal Natural products 0.000 description 1
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000012751 sunset yellow FCF Nutrition 0.000 description 1
- 239000004173 sunset yellow FCF Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- 229960000943 tartrazine Drugs 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/184—Hormones
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/10—Culture of aquatic animals of fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Environmental Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Insects & Arthropods (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Farming Of Fish And Shellfish (AREA)
Abstract
The invention aims to provide high-quality edible cultured eels with high lipid content in skeletal muscle. The present invention provides high quality edible cultured eels having a high level of lipid content in skeletal muscle, edible cultured eel populations containing such eel individuals, and the like. According to the lipid content degree in skeletal muscle of eel, the present invention includes edible cultured eel satisfying the formula I when the body of eel is reset to X (g) and the lipid/protein ratio is set to Z. Even after the eels grow to be large, the meat of the eels is not hardened, and the soft tenderness, quality and taste of the meat are still good. Z > -0.001X+1.95 (250 < X < 1,800) (I).
Description
Technical Field
The present invention relates to a high-quality edible cultured eel having a high lipid content in skeletal muscle, an edible cultured eel population containing such eel individuals, and the like.
Background
Eel is a generic term for fishes belonging to the genus anguilla of the family anguilla, and 19 species of anguilla japonica, anguilla marmorata, etc. are known in the world. Since ancient times, eel has been used as a food in europe, eastern asia, etc., and especially in japan, has become a popular food material conventionally.
For example, japanese eel (school name "Anguilla japonica") living in the east Asia including Japan is considered to spawn in the vicinity of the Mariana islands in Pacific ocean, and then to become a larvae called Threeds (Leptophalus), which are then transformed into glass eels having a total length of 5 to 6cm and a weight of about 0.2 to 0.3g, which are almost transparent, and which reach coastal areas in east Asia by the flow of black tides. Then, it is presumed that eels (black fries and the like) grow to become due to colonization in inland water areas, coastal areas, brackish water areas and the like, mature for five to more than ten years, and return to the spawning area again. There are almost the same lifestyles as for other eels, although spawning sites, colonisation sites, etc. may be different.
Eel is widely cultivated due to large demand, high profit, etc., and it is said that more than 99% of the total consumption is cultivated eel. At present, the mainstream eel breeding method is a method for capturing natural glass eel which swims to coastal areas as breeding seedlings, releasing the natural glass eel into a breeding pond for breeding, and enabling the natural glass eel to develop. In addition, it has been reported that the complete breeding of the next-generation fries is achieved by growing the fries obtained by artificial hatching into parent eels, but mass production has not been achieved in a commercial scale.
In general, male eels grow slowly after weighing over 300g, and meat becomes hard and the quality and taste become poor. On the other hand, female eels had a growth limit greater than that of male eels, and even if the weight exceeded 300g, the growth did not slow down, and the meat tenderness was maintained, and the quality and taste remained unchanged. However, if raising is performed in a breeding environment at a period from glass eel to small eel, most of male eel becomes, and thus it is difficult to obtain female eel. Therefore, edible eel breeding is carried out on the premise that the edible eel is male eel. That is, in the case where it grows too much, meat becomes hard and quality and taste become poor, thereby losing commercial value, so that the edible cultured eels are usually shipped before their body weight reaches 250 g.
In addition, as a method for female eel, it is known that female eel can be induced by feeding a formula feed with a female hormone (estradiol 17 β) at the time of growing from glass eel to small eel. As a method for female eel without using a hormone, for example, patent document 1 describes a method for promoting female eel by raising eel before sexual differentiation in a water tank in which a hollow housing member is disposed so as to cover the whole body of eel that has entered inside.
Here, soybean isoflavone will be described below as a relevant matter of the present invention.
Soy isoflavones are a general term for flavonoid compounds having isoflavone as a basic skeleton, and are mainly contained in soybean germs and the like in large amounts. Soy isoflavones are classified into 4 types of glycosides (glycoside; structure covalently bound to sugar), aglycones (non-glycoside; structure with sugar moiety of glycoside detached), acetylated forms of glycoside, and malonyl forms of glycoside. There are 3 compounds in each classification, and there are 12 compounds in total for soybean isoflavone. Wherein the 3 kinds of isoflavone are genistin, daidzin and glycitin, and their aglycone (sugar part is separated) is genistein, daidzein and glycitein. The composition and content of each compound vary depending on the type of soybean or the like as a raw material, extraction, purification, treatment methods, and the like. Further, as a method for separating a specific compound in soybean isoflavone, for example, patent document 2 discloses a method for separating high purity genistein from an isoflavone mixture using a solvent.
Soy isoflavones have a chemical structure similar to female hormones (estrogens), also known as phytoestrogens. Furthermore, aglycone type soybean isoflavone has estrogen-like action and is said to be effective for preventing heart disease, climacteric disturbance, osteoporosis, breast cancer, etc.
In addition, non-patent document 1 describes that 55% of the eels are female when fed with 2mg/kg (dry feed) of genistein per day for 100 days, whereas only 15% are female when fed with a relatively high amount of 20mg/kg (dry feed) per day.
[ patent document 2] Japanese patent laid-open No. 7-173148
[ non-patent document 1]Itai Tzchori,et al, "The influence of phytoestrogens and oestradiol-17β on growth and sex determination in the European eel (Anguilla Anguilla)", aquaculture Research,2004,35,1213-1219.
Disclosure of Invention
Problems to be solved by the invention
As described above, when raising is performed in a breeding environment at a period from glass eel to small eel, most of the male eel is obtained. Since male eels are difficult to grow to medium or more and meat becomes hard and quality and taste are deteriorated as they grow, edible cultured eels circulated in the market are basically small in size and weight of 200 to 250g, and even medium or more edible cultured eels have a low level of lipid content in skeletal muscle and deteriorated quality and taste as compared with natural eels, especially those natural female eels, which are caught and consumed after growing in natural environment.
On the other hand, at present, no technology for producing female eels simply, safely and stably in a breeding environment has been established, and therefore, it has not been possible to produce and supply to the market edible breeding eels with high lipid content in large and medium skeletal muscles and good quality and taste.
Accordingly, an object of the present invention is to provide a high-quality edible cultured eel having a high lipid content in skeletal muscle in medium or above.
Means for solving the problems
The inventors of the present invention succeeded in realizing simple and stable female eel production in a breeding environment by feeding eel feeds or the like containing soybean isoflavone to glass eels and eels in the period of time of small eels, thereby realizing production and mass production of high-quality edible breeding eels with a medium or higher lipid content in skeletal muscle for the first time.
Accordingly, the present invention provides a high-quality edible cultured eel having a high lipid content in skeletal muscle, which is medium or more, and an edible cultured eel population or the like containing such eel individuals.
According to the degree of lipid content in skeletal muscle of eel, the present invention comprises an edible cultured eel which satisfies the following formula I when the body of eel is reset to X (g) and the lipid/protein ratio is set to Z.
Z>-0.001X+1.95(250<X<1,800)(I)
The food-cultured eel also contains a cultured eel having a body weight of more than 250g, and satisfying the following formula II, wherein the BMI is a value obtained according to the following formula A, and the BMI is Y and the lipid/protein ratio is Z.
BMI = body weight (g)/{ full length (mm) } 2 (A)
Z>-Y+2.45(0.2<Y<2.0)(II)
Further comprises an edible cultured eel having a body weight of more than 250g, and satisfying the following formula III, wherein a (%) is the gonad weight per unit body weight and b (N) is the breaking load of meat when heat-treated for 10 minutes.
b<2a+1(0.1<a<4)(III)
By allowing the eel to ingest the soybean isoflavone-added eel feed or the like during a predetermined period of time during which the glass eel grows into the small eel, for example, during a period when the sex or sex plasticity is not specified, a simple, efficient and stable female eel production can be realized in a breeding environment. Thus, the production and mass production of high-quality edible cultured eels with high fat tissue ratio in skeletal muscle can be realized.
In the present invention, the term "small eel" means an eel fry which grows larger than a glass eel. For convenience, the eels having a weight of less than 0.5g will be hereinafter referred to as glass eels, and eels having a weight of 0.5g or more will be hereinafter referred to as small eels.
ADVANTAGEOUS EFFECTS OF INVENTION
According to the present invention, it is possible to provide high-quality edible cultured eels and the like having a high lipid content in skeletal muscle.
Detailed Description
< edible cultured eel of the present invention >
The invention widely comprises medium-sized or above high-quality edible cultured eels with high lipid content in skeletal muscle.
The edible cultured eel of the present invention has a size of medium or more, specifically, a body weight of preferably more than 250g, more preferably more than 300g, and most preferably more than 350g. Furthermore, the eel weight is preferably less than 1,800g, more preferably less than 1,500g, most preferably less than 1,200g.
Furthermore, the edible cultured eels of the present invention broadly include eels having a body weight within the above-mentioned range and a high level of lipid content in skeletal muscle, i.e., those eels whose meat is not hardened even after growing to a body weight of, for example, more than 250g, and whose soft tenderness, quality and taste remain good.
In the present invention, it was newly found that there is a prescribed correlation between the weight of eel and the lipid/protein ratio, depending on the degree of lipid content in skeletal muscle of eel. Based on this finding, the present invention also includes edible cultured eels satisfying the following formula I' when the body of eels is reset to X (g) and the lipid/protein ratio is set to Z.
Z>-0.001X+1.95(I’)
In formula I', the range of eel body weight X is as described above.
In the formula I', the lipid/protein ratio Y can be obtained by a known nutrient analysis method or the like. For example, skeletal muscle such as the back and abdomen of eel can be extracted, and the protein and lipid amounts can be measured by known nutrition analysis to calculate the lipid/protein ratio.
In the present invention, it was also newly found that there was a predetermined correlation between BMI (body mass index) value of eel and lipid/protein ratio, depending on the degree of lipid content in skeletal muscle of eel. Based on this finding, the present invention also includes edible cultured eels satisfying the following formula II' when the BMI is defined as a value obtained according to the following formula a, the BMI value is defined as Y, and the lipid/protein ratio is defined as Z.
BMI = body weight (g)/{ full length (mm) } 2 (A)
Z>-Y+2.45(II’)
In formula II', the BMI value Y is preferably greater than 0.2, more preferably greater than 0.5, and most preferably greater than 0.8. Furthermore, the BMI value Y is preferably less than 2.0, more preferably less than 1.8. The lipid/protein ratio is the same as described above.
In the present invention, it has been newly found that the lipid content in skeletal muscle of eel has a predetermined relationship with the breaking load of meat during heat processing. Based on this finding, the present invention also includes edible cultured eels satisfying the following formula III' when the gonad weight per body weight is a (%), and the breaking load of the meat at 10 minutes of heat treatment is b (N).
b<2a+1(III’)
The gonad weight per body weight, i.e., the gonad weight index a (%), can be calculated by a known method, for example, the gonad is extracted from an individual eel and the weight is measured, divided by the body weight multiplied by 100. In formula III', the gonadal weight index a is preferably greater than 0.1%, more preferably greater than 0.35%. Furthermore, the gonadal weight index a is preferably less than 4%, more preferably less than 3%, most preferably less than 2%.
The breaking load b (N) of the meat at 10 minutes of heat treatment is obtained as an index of hardness of the meat after heat cooking, and can be measured by a known method. For example, one side of eel is cooked at a temperature of 510,000[ deg.C.sec ], and both sides are cooked. The single-sided cooking may be performed at 600 to 1,000 ℃ for 510 to 850 seconds, for example. The cooking apparatus is preferably an electrothermal oven. After the heating and cooking are performed, the breaking load b is measured for a specific portion (abdomen, etc.) of the meat after the heating and cooking by an elastic measuring device such as a rheometer.
In addition, in the case of eating and breeding eel having a high lipid content in the skeletal muscle of large and medium size, the adipose tissue in the skeletal muscle of the back or abdomen is in a net-like local state.
Here, the term "a state in which adipose tissue is present locally in a net" means that adipose tissue is deposited in an irregular net shape in the entire muscle, and the deposition rate is higher than that of a standard eel, and adipose tissue is extremely fine. Although different in species, it corresponds to grade 4 and grade 5 of the meat quality grade in the beef carcass trade criteria defined by the japanese meat grading association of the corporate community. Of the eels which are the subjects of the present invention, those which are more remarkable in the body side muscles can be said to correspond to eels having an adipose tissue area ratio (adipose tissue area/total cross-sectional area) of 35% or more in the body side muscles. The fat tissue area ratio of the body side muscle on the abdominal side is generally higher than that on the dorsal side, and 37% or more of the body side muscle on the abdominal side can be used as an index.
The type of eel to be the subject of the present invention is not particularly limited as long as it belongs to the genus eel of the family eel. For example, japanese eel (school name "Anguilla japonica"), anguilla marmorata (school name "Anguilla marmorata"), european eel (school name "Anguilla anguilla"), american eel (school name "Anguilla rostrata") and the like are also subjects. In the present invention, the eel is most preferably Japanese eel.
< population of edible cultured eel according to the present invention >
As described above, since eels in the raised collar are basically male eels, there are no large concentrations of medium-sized or medium-sized eels with a high level of lipid in skeletal muscle in the market. That is, according to the present invention, such edible cultured eels can be concentrated in the market for the first time, and the present invention includes all of the plurality of populations formed by the individual edible cultured eels described above.
In view of the fact that the female eel production rate in the breeding environment is substantially 0%, for example, an edible breeding eel population containing the edible breeding eel individuals described above at a rate of 12% or more, formed of 10 or more, more preferably an edible breeding eel population containing the edible breeding eel individuals described above at a rate of 15% or more, and most preferably an edible breeding eel population containing the edible breeding eel individuals described above at a rate of 25% or more, is not likely to be produced before the present invention, and is therefore included in the scope of the edible breeding eel population of the present invention.
< production method of edible cultured eel and the like according to the present invention >)
The production method of the edible cultured eel or the like of the present invention is not particularly limited. For example, these edible cultured eels and the population thereof can be produced and mass-produced by taking an eel feed or an eel femaleization inducer, which will be described later, in the period of glass eels and/or small eels. The present invention is not limited narrowly to production and mass production by the methods shown below.
The male/female differentiation is performed at a predetermined period between the growth of the eel from the glass eel to the small eel (for example, during the growth period of 0.2g to 30g in weight), and when the growth reaches the level of 30g in weight or more, the male/female differentiation can be performed by observing the gonad morphology. Furthermore, by taking in these eel feeds or eel females before and after the time of male and female differentiation, for example, in the time of glass eel and/or small eel, it is possible to reliably and efficiently induce eel females, and thereby it is possible to produce and mass-produce high-quality edible cultured eels (populations) having a medium or higher lipid content in skeletal muscle.
The method for making eel ingest eel feed or eel feminization inducer is not particularly limited. For example, they may be fed with a feed for eel or an inducer for eel femaleization, they may be taken separately, they may be administered directly to an individual eel, or the like.
The period for taking in the eel feed or the eel femaleization inducer is not particularly limited as long as it includes a period of male and female differentiation and a period before and after the male and female differentiation. For example, when the eel is continuously taken in the feed or the eel femaleization inducer for eel during 2 to 6 months of the period of glass eel and/or small eel, the eel can be reliably and efficiently induced with a high possibility of being femaleized.
The frequency of intake of the eel feed or the eel femaleization inducer into the eel is not particularly limited as long as the intake can be continued without interruption during the period of intake or the like. For example, when eel is ingested for 3 to 7 days per week, the eel can be reliably and efficiently induced to be female. The amount taken daily can be further divided into 2 to 3 feeds depending on the growth degree of eel, for example, in the period of glass eel to small eel (for example, weight of 0.2g to 20 g), and the amount taken daily can be fed once in the period of small eel (for example, weight of 20g to 30 g).
< feed for eel >)
In the production of the edible cultured eel (or population thereof) of the present invention, for example, eel feed can be used: eel feed containing soybean isoflavone in an amount of 0.05 wt% or more based on dry matter, eel feed containing soybean isoflavone aglycone in an amount of 0.05 wt% or more based on dry matter, eel feed containing genistein in an amount of 0.006 wt% or more based on dry matter, etc.
By adding soybean isoflavone (or soybean isoflavone aglycone, or one or more specific compounds such as genistein) to the eel feed, the feed can be fed for a certain period of time during which the eel is glass and/or small eel, and the female eel can be induced, thereby enabling production and mass production of high-quality edible cultured eel having a medium or higher fat tissue ratio in skeletal muscle.
The formula feed used as the feed for eel is often fed to eel after being kneaded into paste by adding water, feed oil (fish oil) and the like.
In the eel feed, the soybean isoflavone is preferably contained in an amount of 0.05 wt% or more, more preferably 0.2 wt% or more, and most preferably 1.0 wt% or more, based on the dry feed (hereinafter, the same applies) ratio, that is, based on the weight of the feed before the preparation (addition of water or the like) in use. The upper limit of the soybean isoflavone content is not particularly limited, but is preferably 20% by weight or less, more preferably 8.0% by weight or less, and most preferably 4.0% by weight or less from the viewpoint of feed efficiency.
The soybean isoflavone is not particularly limited, and can be widely used. For example, an off-the-shelf product may be used, or soybean isoflavone prepared by extracting, purifying, treating from raw soybean or the like by a known method may be used.
From other points of view, in the eel feed, the soybean isoflavone aglycone is preferably contained in an amount of 0.05% by weight or more, more preferably 0.2% by weight or more, and most preferably 1.0% by weight or more, based on the dry matter, that is, based on the weight of the feed before the preparation (addition of water or the like) in use. The upper limit of the soybean isoflavone aglycone content is not particularly limited, but is preferably 20% by weight or less, more preferably 8.0% by weight or less, and most preferably 4.0% by weight or less from the viewpoint of feed efficiency or the like. The term "soybean isoflavone aglycone" is a non-sugar moiety in soybean isoflavone (hereinafter, the same applies), and the weight of the non-sugar moiety can be obtained by, for example, converting the ratio of the molecular weight of the glycoside to the molecular weight of the aglycone based on the weight of soybean isoflavone to be added, and can be obtained by analyzing the resultant by a known test method.
From another viewpoint, in the eel feed, when the weight of the feed before the preparation (addition of water or the like) in terms of the dry matter is 100%, genistein is preferably contained in an amount of 0.006% by weight or more, more preferably 0.02% by weight or more, and most preferably 0.1% by weight or more. The upper limit of the genistein content is not particularly limited, but is preferably 5.0 wt% or less, more preferably 2.0 wt% or less, and most preferably 1.0 wt% or less from the viewpoint of feed efficiency or the like.
The method for adding genistein to eel feed is not particularly limited. For example, genistein can be contained in eel feed by adding genistein-containing soybean isoflavone to eel feed; genistein can also be directly added into eel feed; the soybean isoflavone or genistein may also be contained in advance in the production stage of the feed.
Genistein is not particularly limited, and any known genistein can be used. For example, a ready-made product, soybean isoflavone containing genistein as it is, genistein isolated or purified by extraction, purification, treatment from soybean isoflavone or the like by a known method, genistein obtained by separation, extraction, fermentation or the like from beans or processed products thereof by a known method, and genistein synthesized by a known method may be used. For example, in the case where the soybean isoflavone contains genistein in an amount of 10% by weight or more, there are the following advantages: is easy to obtain, manufacture and prepare, and can reliably and efficiently induce female eel, thereby being capable of producing and mass-producing high-quality edible cultured eel with medium or higher fat tissue ratio in skeletal muscle.
In addition, the genistein herein also includes a pharmacologically acceptable salt thereof and a derivative of genistein, as long as the effect of inducing female eel is maintained.
The eel feed contains at least soybean isoflavone (or soybean isoflavone aglycone, or one or more specific compounds such as genistein), and optionally other ingredients, components, etc.
For example, the formulation and the component composition other than soybean isoflavone (or soybean isoflavone aglycone, or one or more specific compounds thereof) in the eel feed may be the same as those of the commonly used formulation feed. The formula feed is a feed in which nutrients necessary for eel growth are mixed in a proper ratio, for example, 50% by weight or more of fish meal in terms of the ratio in dry matter, and further contains starch, calcium phosphate, salt, yeast, herbal extract, etc.
The fish meal in the formula feed may be widely used, and is not particularly limited, and may be, for example, a powder obtained by processing sardine, mackerel, herring, horse mackerel, and the like. The fish meal may be fish meal of other fish species, or may be a mixed powder of fish meal of a plurality of fish species. The type, growth state, cost, etc. of eel can be appropriately selected.
In addition, for example, components for improving the growth efficiency of eel such as lactic acid bacteria, butyric acid bacteria, digestive enzymes, dried vegetables and the like may be suitably contained.
< inducer for eel feminization >)
In the production of the edible cultured eel (or population thereof) of the present invention, for example, an eel femaleization inducer may be used: an eel femaleization inducer containing soybean isoflavone of 10mg/kg or more (weight of eel, hereinafter the same) per day as an active ingredient, an eel femaleization inducer containing soybean isoflavone aglycone of 10mg/kg or more per day as an active ingredient, an eel femaleization inducer containing genistein of 1.2mg/kg or more per day as an active ingredient, and the like.
By incorporating soybean isoflavone (or soybean isoflavone aglycone, or one or more specific compounds such as genistein) as an active ingredient into an eel female inducer, eel female can be induced reliably and efficiently in a glass eel and/or a small eel stage by taking soybean isoflavone or the like, and thus a high-quality edible cultured eel having a medium or higher fat tissue ratio in skeletal muscle can be produced and mass produced.
In the case of the formula feed, the standard of the feed amount is usually 5 to 8% of the weight of the glass eel to the small eel (for example, the weight of the small eel is on the order of 0.2g to 20 g), and 2 to 3% of the weight of the small eel (for example, the weight of the small eel is on the order of 20g to 30 g) depending on the growth condition. The amount of soybean isoflavone to be fed is preferably at least 10mg/kg per day, more preferably at least 40mg/kg per day, and most preferably at least 200mg/kg per day, based on 2% of the body weight. From the viewpoint of feed efficiency, the amount of soybean isoflavone to be fed is preferably 16g/kg or less per day, more preferably 6.4g/kg or less per day, and most preferably 3.2g/kg or less per day, based on 8% of the body weight.
For example, according to the growth degree of eel, soybean isoflavone of 25mg/kg to 16g/kg (eel body weight) is taken daily in the period of glass eel to small eel (for example, the body weight is slightly more than 0.2g and slightly less than 20 g), more preferably 100mg/kg to 6.4g/kg, most preferably 500mg/kg to 3.2g/kg daily; in the period of about 20g or more to about 30g of the small eel, 10mg/kg to 16g/kg (eel weight) of soybean isoflavone, more preferably 40mg/kg to 6.4g/kg, and most preferably 200mg/kg to 3.2g/kg are taken daily.
From another viewpoint, in the eel femaleization inducer, the feed amount is set to 2% of the body weight, preferably 10mg/kg or more of soybean isoflavone aglycone is taken daily, more preferably 40mg/kg or more is taken daily, and most preferably 200mg/kg or more is taken daily. From the viewpoint of feed efficiency, the intake amount of soybean isoflavone aglycone is preferably 16g/kg or less per day, more preferably 6.4g/kg or less per day, and most preferably 3.2g/kg or less per day, with the feed amount being 8% of the body weight.
For example, according to the growth degree of eel, for example, 25mg/kg to 16g/kg (eel weight) of soybean isoflavone aglycone is taken daily in the period of glass eel to small eel (for example, the weight is slightly more than 0.2g and slightly less than 20 g), more preferably 100mg/kg to 12g/kg, most preferably 500mg/kg to 8g/kg daily; in the period of about 20g or more to about 30g of the small eel, 10mg/kg to 16g/kg (eel weight) of soybean isoflavone aglycone is taken daily, more preferably 40mg/kg to 6.4g/kg daily, and most preferably 200mg/kg to 3.2g/kg daily.
From another aspect, in the eel femaleization inducer, the feed amount is set to 2% of the body weight, preferably 1.2mg/kg or more of genistein is taken daily, more preferably 4.0mg/kg or more, and most preferably 20mg/kg or more is taken daily. From the viewpoint of feed efficiency, the amount of fed is 8% by weight, and the amount of genistein taken is preferably 4.0g/kg or less per day, more preferably 1.6g/kg or less per day, and most preferably 0.8g/kg or less per day.
For example, according to the growth degree of eel, for example, 3mg/kg to 4.0g/kg (eel body weight) of genistein is taken daily in the period of glass eel to small eel (for example, the body weight is slightly 0.2g or more and slightly less than 20 g), more preferably 10mg/kg to 1.6g/kg, most preferably 50mg/kg to 800mg/kg daily; the genistein is preferably taken at a daily dose of 1.2 to 1.5 mg/kg (eel body weight), more preferably at a daily dose of 4 to 600mg/kg, most preferably at a daily dose of 20 to 300mg/kg, in the period of about 20g or more to about 30g of eel body weight.
The eel femaleization inducer may be appropriately added with excipients, lubricants, binders, disintegrants, solvents, dissolution aids, suspending agents, buffers, isotonic agents, preservatives, antioxidants, pH adjusters, dispersants, colorants, antifoaming agents and the like according to purposes, uses, dosage forms and the like.
Preferable examples of the excipient include lactose, white sugar, D-mannitol, starch, crystalline cellulose, and light anhydrous silicic acid.
Preferable examples of the lubricant include magnesium stearate, calcium stearate, talc, and colloidal silica.
As preferable examples of the binder, crystalline cellulose, white granulated sugar, D-mannitol, dextrin, hydroxypropyl cellulose, hydroxypropyl methylcellulose, polyvinylpyrrolidone, and the like can be used.
As preferable examples of the disintegrating agent, starch, carboxymethyl cellulose, calcium carboxymethyl cellulose, croscarmellose sodium, sodium carboxymethyl starch and the like can be used, for example.
As preferable examples of the solvent, water for injection, alcohol, propylene glycol, polyethylene glycol (MACROCOL), sesame oil, corn oil and the like can be used.
As preferable examples of the dissolution aid, polyethylene glycol, propylene glycol, D-mannitol, benzyl benzoate, ethanol, triaminomethane, cholesterol, triethanolamine, sodium carbonate, sodium citrate, and the like can be used, for example.
Preferable examples of the suspending agent include surfactants (e.g., stearyl triethanolamine, sodium lauryl sulfate, lauryl aminopropionic acid, lecithin, benzalkonium chloride, benzethonium chloride, and glyceryl monostearate), hydrophilic polymers (e.g., polyvinyl alcohol, polyvinylpyrrolidone, sodium carboxymethyl cellulose, methylcellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, and hydroxypropyl cellulose), and the like.
As preferable examples of the buffer, for example, a buffer such as phosphate, acetate, carbonate, citrate, tartrate, tris, HEPES and the like can be used.
As preferable examples of the isotonic agent, sodium chloride, glycerol, D-mannitol and the like can be used.
Examples of the agents for the purpose of preservation include thimerosal, parabens, phenoxyethanol, chlorobutanol, benzyl alcohol, phenethyl alcohol, dehydroacetic acid, sorbic acid, various other preservatives, antibiotics, and synthetic antibiotics.
As preferable examples of the antioxidant, sulfite, ascorbic acid, and the like can be used.
Preferable examples of the pH adjuster include acids such as hydrochloric acid, carbonic acid, acetic acid, citric acid, phosphoric acid, boric acid, and sulfuric acid, alkali metal hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide, alkali metal carbonates and hydrogencarbonates such as sodium carbonate, alkali metal acetates such as sodium acetate, alkali metal citrates such as sodium citrate, bases such as tromethamine (tromamol), monoethanolamine, and diisopropanolamine.
Preferable examples of the dispersant include sodium carboxymethyl cellulose, hydroxypropyl methyl cellulose, polyvinylpyrrolidone, and Polysorbate (Polysorbate) 80.
Preferred examples of the coloring agent include caramel color, gardenia color, anthocyanin color, annatto color, red pepper color, safflower color, monascus color, carotene color, carotenoid color, flavonoid color, cochineal color, amaranth (red No. 2), erythrosin (red No. 3), allura red AC (red No. 40), carmine (red No. 102), fluorescent pink (red No. 104), rose bengal (red No. 105), acid red (red No. 106), tartrazine (yellow No. 4), sunset yellow FCF (yellow No. 5), fast green FCF (green No. 3), brilliant blue FCF (blue No. 1), indigo carmine (blue No. 2), copper chlorophyll, sodium copper chlorophyll, and the like.
Examples of the defoaming agent include dimethicone (dimethicone), simethicone (Simethicone), silicone emulsion, sorbitan sesquioleate, and nonionic substances.
In addition to the above, the present agent may suitably contain auxiliary components such as light-absorbing pigments (riboflavin, adenine, adenosine, etc.), chelating agents and reducing agents (vitamin C, citric acid, etc.) for stabilization, carbohydrates (sorbitol, lactose, mannitol, starch, sucrose, glucose, dextran, etc.), casein digests, various vitamins, lactic acid bacteria, butyric acid bacteria, digestive enzymes, dried vegetables, etc., as storage and efficacy aids.
Example 1
In example 1, it was investigated whether soybean isoflavone could be used to induce female eel.
The glass eels (average weight: 0.4 g) of undetermined sex were placed in 150L FRP water tanks, fed with the formula feed containing soybean isoflavone at each ratio in a saturated state, and fed at 28℃in water.
The feeding frequency of the formula feed added with the soybean isoflavone is 5 times per week. The initial two months of feed was 7-8% of body weight, followed by about 2.5% of body weight.
After about 6 months from the start of feeding, individuals who had grown into small eels weighing about 30g or more were sampled appropriately, and a determination of the sex was made.
The sex determination is to determine that an individual having an ovary is female and an individual having a testis is male based on morphological observation of gonads.
The results are shown in tables 1 and 2. In each table, "the number of individuals of the sampled eel," the ratio of soybean isoflavone addition "means the ratio of the soybean isoflavone addition amount (wt%) when the weight of the formula feed before soybean isoflavone addition and before preparation at the time is 100%, the" aglycone content ratio "means the ratio of the soybean isoflavone aglycone content weight (wt%) when the weight of the formula feed before soybean isoflavone addition and before preparation at the time is 100%, the" genistein content ratio "means the ratio of the genistein content weight (wt%) when the weight of the formula feed before soybean isoflavone addition and before preparation at the time is 100%, and the" ratio of female "means the ratio of female in the sampled individual number. In addition, "soybean isoflavone aglycone containing weight" means the weight of the non-sugar part in the added soybean isoflavone, and an analytical value obtained based on a known test method is used. The "control" is the result of feeding the normal formula feed without soybean isoflavone instead of the above.
TABLE 1
TABLE 2
As shown in Table 1, femaleization of eel was induced by feeding eel with soybean isoflavone in an amount of 1 wt% or more in the feed for eel at the time of glass eel to small eel. As shown in table 2, when the eel feed was fed with the feed containing 0 to 0.040 wt% of aglycone based on the weight of the feed, all individuals differentiated to males, whereas when the aglycone content was 0.100 wt% or more, 46% of individuals were induced to females, 0.336 wt% of individuals were induced to females, and 1.076 wt% or more, all individuals were induced to females. From another viewpoint, attention is paid to genistein contained in a feed by adding soybean isoflavone, and when feeding a feed for eel having a genistein content ratio of 0 to 0.004 wt% in the period of glass eel to small eel, all individuals are differentiated into males, when the genistein content ratio is 0.01 wt%, 46% of individuals are induced into females, when 0.031 wt%, 95% of individuals are induced into females, and when the genistein content ratio is 0.155 wt% or more, all individuals are induced into females.
According to the feeding amount of each of the experiments, the amount of soybean isoflavone was about 700 to 800mg/kg body weight for the first two months, and the amount of soybean isoflavone was about 250mg/kg body weight for the second two months, in terms of conversion to 7 to 8% by weight for the first two months and about 2.5% by weight for the second month, when the soybean isoflavone addition ratio was 1% by weight. Similarly, when the content ratio of aglycone to the weight of the feed is 0.100% by weight, the amount of aglycone taken in each of the first two months is about 70.0 to 80.0mg/kg body weight, and thereafter the amount of aglycone taken in each of the two months is about 25.0mg/kg body weight; in the case where the content ratio of the aglycone relative to the weight of the feed is 0.336 wt%, the intake amount of the aglycone is about 235.2 to 268.8mg/kg body weight for each of the first two months, and thereafter, the intake amount of the aglycone is about 84.0mg/kg body weight for each of the two months; in the case where the content ratio of aglycone to the weight of the feed is 1.076 wt%, the amount of aglycone taken in each of the first two months is about 753.2 to 860.8mg/kg body weight, and thereafter the amount of aglycone taken in each of the two months is about 269.0mg/kg body weight. Further, in the case where the genistein content ratio is 0.01% by weight, the amount of genistein taken up each time for the first two months is about 7 to 8mg/kg body weight, and thereafter the amount of genistein taken up each time is about 2.5mg/kg body weight; in the case where the genistein content ratio is 0.031 wt%, the amount of genistein taken up each time for the first two months is about 21.70 to 24.8mg/kg body weight, and thereafter about 7.75mg/kg body weight; in the case where the genistein content ratio is 0.155% by weight, the uptake amount of genistein per time for the first two months is about 108.5 to 1,240mg/kg body weight, and thereafter the uptake amount of genistein per time is about 38.75mg/kg body weight.
Example 2
In example 2, male and female were compared based on analysis of the overall length and weight of eel and nutrient content.
Full length and body weight were measured for eels not induced to be feminized with soy isoflavones (male eels, n=7) and eels induced to be feminized with soy isoflavones (female eels, n=5), respectively. Then, for each individual, a BMI value was calculated using the above formula a.
Next, skeletal muscles of the back and abdomen were extracted, analyzed for nutritional components, the protein mass and the lipid mass were measured, and the lipid/protein ratio in skeletal muscles of the back and abdomen was calculated.
FIG. 1 is a graph comparing body weight and lipid/protein ratio between male and female. In the figure, the horizontal axis represents body weight (g), and the vertical axis represents lipid/protein ratio.
As shown in fig. 1, when the body of eel is reset to X (g) and the lipid/protein ratio is Z, the female and male eel can be clearly identified by using the following formula i″ as a boundary.
Z=-0.001X+1.95(I”)
FIG. 2 is a graph comparing BMI values and lipid/protein ratios between females and males. In the figure, the horizontal axis represents the BMI value, and the vertical axis represents the lipid/protein ratio.
As shown in fig. 2, when the BMI value is Y and the lipid/protein ratio is Z, the male and female can be clearly identified by using the following formula ii″ as a boundary for the cultured eel.
[ number 10]
Z=-Y+2.45(II”)
Example 3
In example 3, the gonadal weight index (GSI; gonadal weight/body weight) of eel that was induced to female with soybean isoflavone was calculated, and the relationship between the gonadal weight index and the hardness of cooked meat was evaluated.
First, weights of eels (male eels, n=12, weights of 200 to 350 g) not having been subjected to the soybean isoflavone-induced female formation and eels (female eels, n=15, weights of 200 to 530 g) having been subjected to the soybean isoflavone-induced female formation were measured separately, and genitals were extracted to measure the weights. Furthermore, the gonadal weight per body weight (unit:%) was calculated as the gonadal weight index.
As a result, the gonad weight per unit weight of all male eels was 0.35% or less, whereas the gonad weight per unit weight of all female eels whose femaleization was induced by soybean isoflavone was more than 0.35%.
Then, each eel was cut along the center of the ventral side, each eel was subjected to heat treatment at 850℃for 600 seconds on the skin side and 600 seconds on the meat side using an electric oven 3H-210 (manufactured by Higo Griller Co.), each dried eel was prepared, the skin was peeled off, fish pieces having a width of about 1cm were prepared from 3 portions on the ventral side, and then the breaking load at the time of cutting the meat at the tip portion of each wedge-shaped fitting was measured by a rheometer for 3 samples of 1 individual, and the average value was used as an index of the hardness of the meat.
Fig. 3 is a graph showing the relationship between the gonadal weight index and the breaking load of the ventral meat after heat cooking. In FIG. 3, the horizontal axis represents the gonadal weight index (GSI; gonadal weight per body weight:%) of eel, and the vertical axis represents the breaking load (unit: N) of the belly side meat after cooking by heating.
As shown in fig. 3, when the gonad weight index is a (%) and the breaking load of the abdominal side meat after the heating and cooking is b (N), the male and female eel can be clearly identified by using the following formula III "as a boundary.
Y=2X+1(III”)
Drawings
FIG. 1 is a graph showing comparison of body weight and lipid/protein ratio between the male and female in example 2.
FIG. 2 is a graph showing comparison of BMI values and lipid/protein ratios between the male and female in example 2.
Fig. 3 is a graph showing the relationship between the gonadal weight index and the breaking load of the ventral meat after the heat cooking in example 3.
Claims (6)
1. An edible cultured eel satisfying the following formula I when the body of the eel is reset to X (g) and the lipid/protein ratio is set to Z:
Z>-0.001X+1.95(250<X<1,800) (I)。
2. an edible eel for breeding with weight of more than 250g
When a value obtained according to the following formula a is defined as BMI, and the BMI value is defined as Y and the lipid/protein ratio is defined as Z, the following formula II is satisfied:
BMI = body weight (g)/{ full length (mm) } 2 (A)
Z>-Y+2.45(0.2<Y<2.0) (II)。
3. An edible eel for breeding with weight of more than 250g
When the gonadal weight per unit body weight is a (%) and the breaking load of meat at the time of heat treatment for 10 minutes is b (N), the following formula III is satisfied:
b<2a+1(0.1<a<4) (III)。
4. a food-cultured eel according to any one of claims 1 to 3, wherein adipose tissue in skeletal muscle of the back or abdomen is present locally in a net shape.
5. The edible cultured eel according to any one of claims 1 to 4, wherein during a glass eel and/or a small eel period,
the eel feed containing soybean isoflavone in an amount of 0.05 wt% or more based on the dry matter is ingested.
6. An edible cultured eel population formed from 10 or more, containing the edible cultured eel individual according to any one of claims 1 to 5 at a ratio of 12% or more.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020168025 | 2020-10-02 | ||
JP2020-168025 | 2020-10-02 | ||
PCT/JP2021/036464 WO2022071589A1 (en) | 2020-10-02 | 2021-10-01 | Edible cultured eel |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116390650A true CN116390650A (en) | 2023-07-04 |
Family
ID=80951712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202180067858.8A Pending CN116390650A (en) | 2020-10-02 | 2021-10-01 | Edible eel culture |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPWO2022071589A1 (en) |
KR (1) | KR20230075462A (en) |
CN (1) | CN116390650A (en) |
TW (1) | TW202228527A (en) |
WO (1) | WO2022071589A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024024972A1 (en) * | 2022-07-28 | 2024-02-01 | 国立大学法人北海道大学 | Sturgeon breeding method, sturgeon production method, and solid feed for sturgeon |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140140456A (en) * | 2013-05-29 | 2014-12-09 | 구골홀딩스 주식회사 | Feed composite for inducing feminization of eel and method for promoting feminization of eel with the same and light source |
CN109258541A (en) * | 2018-11-12 | 2019-01-25 | 南京师范大学 | A method of based on ratio Characters Identification Fugu category fish sex |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3078694B2 (en) | 1993-12-17 | 2000-08-21 | キッコーマン株式会社 | How to make genistein |
JP2002330706A (en) * | 2001-05-02 | 2002-11-19 | Nichimo Co Ltd | Aquaculture method using isoflavone aglycon, improving aquaculture environment |
JP2005269913A (en) * | 2004-03-23 | 2005-10-06 | Daicho Kikaku:Kk | Fish feed additive, and fish feed |
JP2005272309A (en) * | 2004-03-23 | 2005-10-06 | Daicho Kikaku:Kk | Chemical for fishes |
JP6985712B2 (en) | 2017-03-07 | 2021-12-22 | 国立大学法人 鹿児島大学 | Eel breeding method |
-
2021
- 2021-09-29 TW TW110136238A patent/TW202228527A/en unknown
- 2021-10-01 KR KR1020237011248A patent/KR20230075462A/en unknown
- 2021-10-01 CN CN202180067858.8A patent/CN116390650A/en active Pending
- 2021-10-01 WO PCT/JP2021/036464 patent/WO2022071589A1/en active Application Filing
- 2021-10-01 JP JP2022554152A patent/JPWO2022071589A1/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140140456A (en) * | 2013-05-29 | 2014-12-09 | 구골홀딩스 주식회사 | Feed composite for inducing feminization of eel and method for promoting feminization of eel with the same and light source |
CN109258541A (en) * | 2018-11-12 | 2019-01-25 | 南京师范大学 | A method of based on ratio Characters Identification Fugu category fish sex |
Non-Patent Citations (2)
Title |
---|
ITAI TZCHORI: ""The influence of phytoestrogens and oestradiol-17b on growth and sex determination in the European eel (Anguilla anguilla)"", 《AQUACULTURE RESEARCH》, vol. 35, 31 December 2004 (2004-12-31), pages 1213 - 1217 * |
叶继丹;陈学豪;: "大豆黄素对美洲鳗生长及肝、肠组织中几种代谢酶活性的影响", 集美大学学报(自然科学版), no. 01, 15 January 2008 (2008-01-15) * |
Also Published As
Publication number | Publication date |
---|---|
TW202228527A (en) | 2022-08-01 |
JPWO2022071589A1 (en) | 2022-04-07 |
KR20230075462A (en) | 2023-05-31 |
WO2022071589A1 (en) | 2022-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0656786B1 (en) | Use of isoflavone phyto-oestrogen extracts of soy or clover | |
JP6970992B2 (en) | Eel femaleization induction method, eel breeding method, eel femaleizing agent, and eel feed | |
CN116390650A (en) | Edible eel culture | |
CN110063427B (en) | Application of wild licorice root extract in preparing anti-stress agent for freshwater fish and preparation method thereof | |
CN104171576B (en) | A kind of stone small water turtle mixed feed | |
CN108124793A (en) | Improve the cultural method of Tilapia quality | |
WO2024172160A1 (en) | Method for promoting growth of eel, method for producing eel, and agent for promoting growth of eel | |
JP5361527B2 (en) | Anemia treatment | |
TW202437920A (en) | Method for promoting the growth of eel, method for production of eel, and eel growth promoter | |
KR100858280B1 (en) | Manufacturing method of Monascus sp., powder, gel, rice with Genistein Combined Monacolin K | |
CN109497335A (en) | A kind of feed formula and method for breeding that can produce the egg containing tea polyphenols | |
CN108739667A (en) | A kind of method that tortoise is raised in rice field | |
AU777632B2 (en) | Health supplements containing isoflavones | |
JP2003155248A (en) | Anticancer composition | |
Kamatit et al. | Effects of Dietary Waterlily (Nymphaea pubescens) Stamens Extract on Growth Performance of Common Lowland Frog (Rana rugulosa) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |